Latest information on COVID-19
Support teaching, research, and patient care.
Kuldev Singh is Professor of Ophthalmology and Director of the Glaucoma Service. After receiving an undergraduate degree majoring in Biology and Economics at McGill University, he received his MD and MPH degrees from the Johns Hopkins University and was a Dana Foundation Fellow at the Wilmer Eye Institute, Johns Hopkins Hospital. Following residency training at the Casey Eye Institute and a Heed Foundation Fellowship at the Bascom Palmer Eye Institute, Dr. Singh joined the Stanford faculty in 1992, rising to the rank of Professor in 2003. He has published over 200 original peer-reviewed articles and delivered over 350 invited lectures including over 70 named or keynote lectures and visiting professorships, edited three textbooks and served on the editorial boards of 11 ophthalmic publications. Dr. Singh’s current academic interests include glaucoma and cataract surgery, the epidemiology of myopia and glaucoma, ophthalmic genetics, as well as health care delivery in underserved communities in the United States and overseas. He is an investigator in the National Institutes of Health funded NEI Glaucoma Human Genetics Collaboration and is funded by the U.S. Food and Drug Administration (FDA) to study patient related outcomes with minimally invasive glaucoma surgery. Dr. Singh's clinical practice focuses on the medical, laser and surgical management of glaucoma and cataract.Dr. Singh has served as President of the American Glaucoma Society, Executive Vice President of the World Glaucoma Association and Board Chair for the Glaucoma Research Foundation and serves on the Advisory Committee of the International Society of Glaucoma Surgery. He serves as a member of the FDA Advisory Committee on Ophthalmic Devices and as an advisor to the UCSF/Stanford Center for Excellence in Regulatory Science and Innovation (CERSI) which is an FDA funded initiative. As a CERSI advisor, Dr. Singh developed the concept for the annual FDA supported UCSF/Stanford Innovations in Regulatory Science Summit for which he serves on the organizing committee. Dr. Singh served as a consultant for the National Space Biomedical Research Institute for which he assisted NASA in solving eye problems related to space travel and was co-chair of the Association for Research in Vision and Ophthalmology ARVO/ARVO Asia Translational Vision Summit Steering Committee. He received the 2015 Life Achievement Honor Award from the American Academy of Ophthalmology (AAO) and delivered the keynote American Glaucoma Society Lecture at the 2017 AAO Glaucoma Meeting.Dr. Singh served as an Academic Advising Dean at the School of Medicine from 2002-2005 and two three year terms as an elected at-large member of the Faculty Senate from 2006-2012. He received the 2006 School of Medicine Franklin G. Ebaugh Jr. Award and was one of two recipients of the 2012 University-wide Asian American Faculty Award. Dr. Singh currently serves on the Organizing Committee of the annual Stanford Drug Discovery Symposium and is co-chair of Ophthalmology Futures Forum, a global ophthalmic innovation meeting.Dr. Singh received the World Glaucoma Association Founder's Award in 2013 and was inducted into the Delta Omega Public Health Honor Society at the Johns Hopkins University Bloomberg School of Public Health as a distinguished alumnus in 2014. A global nomination based survey conducted in 2018 by The Ophthalmologist, a U.K. based publication, ranked Dr. Singh as one of the 15 most influential individuals in ophthalmology worldwide.
Aravind Eye Hospital
Cape Coast Eye Clinic
Glaucoma, clinical epidemiology